179 related articles for article (PubMed ID: 38164882)
1. Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy.
Tabrizian P; Zeitlhoefler M; Hassan AT; Marino R
Curr Opin Organ Transplant; 2024 Apr; 29(2):144-154. PubMed ID: 38164882
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy and transplantation for hepatocellular carcinoma.
Tabrizian P; Abdelrahim M; Schwartz M
J Hepatol; 2024 May; 80(5):822-825. PubMed ID: 38253289
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
Jiang J; Huang H; Chen R; Lin Y; Ling Q
Front Immunol; 2023; 14():1092401. PubMed ID: 36875077
[TBL] [Abstract][Full Text] [Related]
4. The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients.
Ziogas IA; Evangeliou AP; Giannis D; Hayat MH; Mylonas KS; Tohme S; Geller DA; Elias N; Goyal L; Tsoulfas G
Oncologist; 2021 Jun; 26(6):e1036-e1049. PubMed ID: 33314549
[TBL] [Abstract][Full Text] [Related]
5. European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma.
Claasen MPAW; Sneiders D; Rakké YS; Adam R; Bhoori S; Cillo U; Fondevila C; Reig M; Sapisochin G; Tabrizian P; Toso C
Transpl Int; 2023; 36():11648. PubMed ID: 37779513
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for hepatocellular carcinoma: an update.
Zarrinpar A; Kaldas F; Busuttil RW
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):234-42. PubMed ID: 21669564
[TBL] [Abstract][Full Text] [Related]
7. Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma.
Koh B; Tan DJH; Lim WH; Wong JSL; Ng CH; Chan KE; Wang M; Yong WP; Dan YY; Wang LZ; Tan N; Muthiah M; Kow A; Syn NL; Huang DQ; Yau T
Oncoimmunology; 2023; 12(1):2214478. PubMed ID: 37284696
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss.
Wang T; Chen Z; Liu Y; Jia Y; Ju W; Chen M; Zhao Q; Wang D; Guo Z; Tang Y; He X
Liver Transpl; 2023 Jun; 29(6):598-606. PubMed ID: 36747346
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the Safe Washout Period for Liver Transplantation Following Immune Checkpoint Inhibitors with Atezolizumab, Nivolumab, or Pembrolizumab.
Kuo FC; Chen CY; Lin NC; Liu C; Hsia CY; Loong CC
Transplant Proc; 2023 May; 55(4):878-883. PubMed ID: 37127513
[TBL] [Abstract][Full Text] [Related]
10. Current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation.
Wang ZY; Geng L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):145-9. PubMed ID: 25865686
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy and Liver Transplantation: The Future or the Failure?
Tabrizian P; Yu A; Debnath N; Myers B; Marron T
Surg Clin North Am; 2024 Feb; 104(1):163-182. PubMed ID: 37953034
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant therapies in resectable hepatocellular carcinoma: Exploring strategies to improve prognosis.
Ma YN; Jiang X; Song P; Tang W
Biosci Trends; 2024 Mar; 18(1):21-41. PubMed ID: 38382930
[TBL] [Abstract][Full Text] [Related]
13. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
14. Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy?
Jiang C; Sun XD; Qiu W; Chen YG; Sun DW; Lv GY
Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):7-13. PubMed ID: 36825482
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatocellular carcinoma: Management after the transplant.
Verna EC; Patel YA; Aggarwal A; Desai AP; Frenette C; Pillai AA; Salgia R; Seetharam A; Sharma P; Sherman C; Tsoulfas G; Yao FY
Am J Transplant; 2020 Feb; 20(2):333-347. PubMed ID: 31710773
[TBL] [Abstract][Full Text] [Related]
16. [Review and prospect of clinical study on liver transplantation of hepatocellular carcinoma].
Huang XW; Zhou J
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):81-83. PubMed ID: 29804370
[TBL] [Abstract][Full Text] [Related]
17. [Insight and judgment on recurrence of hepatocellular carcinoma after liver transplantation].
Zheng H; Zhang HM; Zheng WP
Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):88-92. PubMed ID: 29804372
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.
Luo Y; Teng F; Fu H; Ding GS
World J Gastrointest Oncol; 2022 Jan; 14(1):163-180. PubMed ID: 35116109
[TBL] [Abstract][Full Text] [Related]
20. Immune Checkpoint Inhibitors in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Case Report and Literature Review.
Qiu J; Tang W; Du C
Curr Cancer Drug Targets; 2020; 20(9):720-727. PubMed ID: 32433005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
